RSLS ReShape Lifesciences Inc. Stock Quote

RSLS [NASD]

Index	-	P/E	-	EPS (ttm)	-4.38	Insider Own	6.20%	Shs Outstand	19.29M	Perf Week	-4.93%
Market Cap	11.19M	Forward P/E	-	EPS next Y	-1.07	Insider Trans	-4.80%	Shs Float	16.39M	Perf Month	-36.58%
Income	-65.30M	PEG	-	EPS next Q	-0.28	Inst Own	18.40%	Short Float	1.80%	Perf Quarter	-49.12%
Sales	12.80M	P/S	0.87	EPS this Y	-4.60%	Inst Trans	1.98%	Short Ratio	1.53	Perf Half Y	-64.63%
Book/sh	2.08	P/B	0.28	EPS next Y	60.50%	ROA	-83.60%	Target Price	3.83	Perf Year	-87.36%
Cash/sh	0.80	P/C	0.73	EPS next 5Y	-	ROE	-117.60%	52W Range	0.55 - 6.25	Perf YTD	-64.63%
Dividend	-	P/FCF	-	EPS past 5Y	32.80%	ROI	-126.80%	52W High	-90.72%	Beta	-0.32
Dividend %	-	Quick Ratio	2.40	Sales past 5Y	32.00%	Gross Margin	56.80%	52W Low	5.45%	ATR	0.08
Employees	47	Current Ratio	2.90	Sales Q/Q	-25.00%	Oper. Margin	-	RSI (14)	34.17	Volatility	8.80% 12.21%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	64.30%	Profit Margin	-	Rel Volume	0.90	Prev Close	0.56
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 23 BMO	Payout	-	Avg Volume	192.73K	Price	0.58
Recom	2.00	SMA20	-14.79%	SMA50	-24.57%	SMA200	-62.89%	Volume	183,998	Change	3.52%

Jun-17-22 08:30AM	ReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds GlobeNewswire
May-26-22 08:30AM	ReShape Lifesciences and OpenLoop Sign Agreement to Provide Nationwide Virtual Health Services for Weight Loss and Wellness Through reshapecare GlobeNewswire +11.25%
May-23-22 08:00AM	ReShape Lifesciences Reports First Quarter 2022 Financial Results and Provides Corporate Update GlobeNewswire
May-19-22 08:30AM	ReShape Lifesciences Announces Vernon Vincent to be Recognized as the Distinguished Industry Partner at the ASMBS 2022 LEAD Gala and Awards GlobeNewswire
May-16-22 08:30AM	ReShape Lifesciences to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update GlobeNewswire
Apr-26-22 08:30AM	ReShape Lifesciences to Present at the Q2 Investor Summit GlobeNewswire -7.26%
Mar-31-22 11:33AM	Earnings Update: ReShape Lifesciences Inc. (NASDAQ:RSLS) Just Reported And Analysts Are Trimming Their Forecasts Simply Wall St. -12.59%
Mar-28-22 04:05PM	ReShape Lifesciences Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update GlobeNewswire
Mar-24-22 08:30AM	ReShape Lifesciences Experiences Continued Momentum of Direct-to-Consumer Marketing Campaign for the Lap-Band® GlobeNewswire
Mar-17-22 09:07AM	ReShape Lifesciences to Announce Financial Results for the Year Ended December 31, 2021 and Provide Corporate Update GlobeNewswire +18.89%
Mar-09-22 08:30AM	ReShape Lifesciences to Participate in Investor Conferences in March GlobeNewswire
Jan-18-22 08:30AM	ReShape Lifesciences to Participate in the American Society for Metabolic and Bariatric Surgerys (ASMBS) Leadership Academy and re-UNITED Meeting January 19-22, 2022 in Las Vegas GlobeNewswire
Jan-13-22 08:30AM	ReShape Lifesciences Strengthens Leadership Team with Appointment of Michael Bordainick as Senior Vice President, Commercial Operations GlobeNewswire
Dec-20-21 08:35AM	Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing PR Newswire
08:35AM	Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing CNW Group
Dec-14-21 08:35AM	Virtual Conference for Life Sciences Companies Broadcast Live December 16th CNW Group
Dec-09-21 12:19PM	Life Sciences Virtual Investor Conference: Company Executives Present Live December 16th PR Newswire -5.45%
08:35AM	ReShape Lifesciences to Webcast Live at Life Sciences Investor Forum on December 16th PR Newswire
Nov-16-21 08:30AM	ReShape Lifesciences Witnesses Great Success with Direct-to-Consumer Marketing Campaign GlobeNewswire
Nov-11-21 08:30AM	ReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results GlobeNewswire
Nov-08-21 08:30AM	ReShape Lifesciences to Report Third Quarter 2021 Financial and Operational Results on Thursday, November 11, 2021 GlobeNewswire
Nov-04-21 08:30AM	ReShape Lifesciences to Launch Line of ProCare Health® Supplements to Meet Consumers Nutritional Needs GlobeNewswire
Oct-19-21 08:30AM	ReShape Lifesciences to Present at Dawson James 6th Annual Small Cap Growth Conference GlobeNewswire
Oct-12-21 08:00AM	ReShape Launches National Advertising Campaign for Flagship Product, Lap-Band® GlobeNewswire
Sep-23-21 08:00AM	ReShape Lifesciences Featured in BioTuesdays GlobeNewswire
Sep-13-21 08:00AM	ReShape Lifesciences to Host Exhibit at Bariatric Summit GlobeNewswire
Sep-09-21 08:30AM	ReShape Lifesciences to Present at Oppenheimer Fall Healthcare Life Sciences and Med Tech Summit on September 20, 2021 GlobeNewswire
Aug-31-21 08:00AM	ReShape Lifesciences Appoints Al Diaz as Vice President of Operations and Research and Development GlobeNewswire
Aug-20-21 12:24PM	Is ReShape Lifesciences (NASDAQ:RSLS) Using Debt Sensibly? Simply Wall St.
Aug-16-21 08:00AM	ReShape Reports Second Quarter 2021 Financial Results and Provides Business Update ACCESSWIRE -10.38%
Aug-05-21 08:00AM	ReShape Lifesciences Reports Preliminary Unaudited Second Quarter 2021 Financial Results and Provides Business Update ACCESSWIRE +7.22%
Aug-03-21 08:00AM	ReShape Lifesciences(TM) CEO Bart Bandy Featured on the Big Biz Show ACCESSWIRE -7.69%
Jul-29-21 08:30AM	ReShape Lifesciences to Report Second Quarter 2021 Financial and Operational Results on Thursday, August 5, 2021 ACCESSWIRE
Jul-13-21 08:30AM	ReShape Lifesciences(TM) Launches Online Consumer Marketplace Offering Products Supporting Four Key Dimensions of Wellness: Nutrition, Exercise, Sleep and Stress ACCESSWIRE -7.84%
Jul-07-21 08:30AM	ReShape Lifesciences Moves Lap-Band Manufacturing to United States ACCESSWIRE
Jul-01-21 08:30AM	ReShape Lifesciences Sees Lap-Band Growth as COVID-19 Pandemic Heightens Obesity Crisis ACCESSWIRE
Jun-30-21 08:30AM	ReShape Lifesciences Completes $46 Million Capital Raise With Key Institutional Shareholders ACCESSWIRE -9.42%
Jun-29-21 09:27AM	ReShape Lifesciences Enters into Warrant Exercise Transaction for $46.2 Million in Gross Proceeds ACCESSWIRE -27.75%
Jun-17-21 08:45AM	ReShape Lifesciences Closes First Day of Trading on the NASDAQ Capital Market ACCESSWIRE -6.51%
Jun-16-21 07:30AM	ReShape Lifesciences Completes Merger with Obalon Therapeutics ACCESSWIRE -31.15%
Jun-15-21 12:05PM	ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger ACCESSWIRE -5.86%
Jun-08-21 07:30AM	ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger ACCESSWIRE
May-24-21 07:30AM	Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences ACCESSWIRE +14.04%
May-21-21 07:30AM	Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences ACCESSWIRE +30.04%
May-18-21 07:30AM	Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021 ACCESSWIRE +22.03%
May-17-21 04:05PM	ReShape Lifesciences Announces First Quarter 2021 Financial and Operational Results ACCESSWIRE
Mar-10-21 04:30PM	ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results ACCESSWIRE +5.37%
Mar-08-21 07:00AM	Reshape Lifesciences to Report Fourth Quarter and Full Year 2020 Financial and Operational Results on Wednesday, March 10, 2021 ACCESSWIRE +7.91%
Jan-22-21 04:46PM	OBALON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of OBLN and Encourages Investors to Contact the Firm GlobeNewswire +15.99%

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bandy Barton P.	President and CEO	Jun 01	Sale	0.95	11,309	10,771	796,214	Jun 06 04:58 PM
STANKOVICH THOMAS	Chief Financial Officer	Jun 01	Sale	0.96	4,478	4,299	361,149	Jun 06 04:49 PM
STANKOVICH THOMAS	Chief Financial Officer	May 31	Buy	0.92	20,000	18,422	365,627	Jun 01 02:18 PM
Bandy Barton P.	President and CEO	May 05	Sale	0.77	11,417	8,791	807,523	May 12 04:13 PM
STANKOVICH THOMAS	Chief Financial Officer	May 05	Sale	0.77	4,529	3,487	345,627	May 12 04:05 PM
STANKOVICH THOMAS	Chief Financial Officer	Apr 01	Sale	1.13	5,038	5,693	350,156	Apr 08 04:27 PM
Bandy Barton P.	President and CEO	Apr 01	Sale	1.13	11,063	12,501	818,940	Apr 08 04:12 PM
STANKOVICH THOMAS	CFO	Feb 28	Sale	1.06	3,658	3,877	355,194	Mar 02 04:15 PM
Bandy Barton P.	President and CEO	Feb 28	Sale	1.06	6,538	6,930	830,003	Mar 02 04:08 PM
Bandy Barton P.	President and CEO	Jan 31	Sale	1.22	8,324	10,155	836,541	Feb 02 04:32 PM
STANKOVICH THOMAS	Chief Financial Officer	Jan 31	Sale	1.22	3,684	4,494	358,852	Feb 02 04:22 PM
Bandy Barton P.	President and CEO	Jan 04	Sale	1.79	7,150	12,798	844,865	Jan 28 04:58 PM
STANKOVICH THOMAS	Chief Financial Officer	Jan 04	Sale	1.78	3,171	5,644	362,536	Jan 28 04:46 PM
Bandy Barton P.	President and CEO	Dec 02	Sale	1.83	13,427	24,571	852,015	Dec 09 04:22 PM
STANKOVICH THOMAS	Chief Financial Officer	Dec 02	Sale	1.83	4,304	7,863	365,707	Dec 09 04:17 PM
STANKOVICH THOMAS	Chief Financial Officer	Nov 18	Buy	2.02	20,000	40,400	370,011	Nov 18 04:32 PM
Bandy Barton P.	President and CEO	Nov 02	Sale	2.69	13,505	36,328	865,442	Nov 16 04:18 PM
STANKOVICH THOMAS	Chief Financial Officer	Nov 02	Sale	2.69	4,320	11,621	350,011	Nov 16 04:14 PM
STANKOVICH THOMAS	Chief Financial Officer	Oct 01	Sale	2.76	3,660	10,102	354,331	Oct 12 07:40 PM
Bandy Barton P.	President and CEO	Oct 01	Sale	2.77	12,565	34,805	878,947	Oct 12 07:35 PM
Bandy Barton P.	President and CEO	Sep 10	Sale	2.89	294,494	851,088	891,512	Sep 17 07:07 PM
STANKOVICH THOMAS	Chief Financial Officer	Sep 10	Sale	2.89	48,366	139,778	357,991	Sep 17 06:51 PM
GLADNEY DAN W	Director	Sep 10	Sale	2.99	200,000	598,000	283,922	Sep 17 06:37 PM
STANKOVICH THOMAS	Chief Financial Officer	Aug 30	Buy	3.43	15,000	51,435	32,613	Aug 31 04:31 PM
STANKOVICH THOMAS	Chief Financial Officer	Aug 20	Buy	3.22	15,000	48,285	17,613	Aug 24 08:59 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience